ArticleGels (Basel, Switzerland)2026
Physicochemical and Mechanical Evaluation of Nanocomposite Cryogels Based on Chitosan and Laponite and Their Potential for Drug Delivery.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
It is known that the controlled release of anticancer drugs with low molecular weight from drug delivery systems (DDSs) based on polysaccharides such as chitosan (CS) still encounter certain difficulties because of the high hydrophilicity of the carrier. The release rate is very fast, with a burst release that is usually obvious. Therefore, finding novel systems to carry and release low molecular weight drugs such as 5-fluorouracil (5-FU) is still of interest. The impact of chitosan (CS) characteristics (deacetylation degree and molar mass), and concentration as well as of the strategy employed to fabricate porous nanocomposites CS-laponite (LAP), on the physicochemical properties of CS-LAP sponges was first investigated in the paper. Information about the incorporation of LAP within the CS-LAP nanocomposites was obtained by EDX and FTIR spectroscopy. The influence of the fabrication conditions on the physical cross-linking was evidenced first by the swelling of the composite sponges at equilibrium in distilled water, with lower values of the swelling ratio found for the composites prepared with one freeze-drying (1FD) step, than of those prepared with 2FD steps. The elastic modulus ranged between 6 and 21 kPa for CS-LAP composites prepared with 1FD, and between 2 and 10 kPa for the nanocomposites prepared with 2FD steps. The physicochemical properties of CS-LAP nanocomposite sponges were correlated with their behavior in the loading and in vitro release of 5-FU as a function of pH. It was found that the CS-LAP composites with the highest swelling ratio exhibited the fastest release of 5-FU in simulated gastric fluid (pH 2.0), with the cumulative release in the range of 85-100%, in about 60 min, at 37 °C. The CS-LAP composites with the lowest swelling ratio, displayed the slowest release rate of drug. The drug release from the double component composites was accompanied by the carrier dissolution/disintegration. To retard the release of 5-FU in the gastric environment, the drug was sealed in the porous CS-LAP nanocomposites by simple complexation of the free positive charges of CS with carboxymethylcellulose as polyanion. These systems kept their integrity at pH 2.0, pH 6.8 and phosphate buffer with pH 7.4, and released 5-FU in a controlled manner, making them suitable systems for delivery of 5-FU in both the stomach and small intestine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.